Prescribing Information & Guidance
Ritlecitinib for treating severe alopecia areata in people 12 years and over. TA958 Published: 27 March 2024
This document has been written by East of England Priorities Advisory Committee (EoE PAC) and has been ratifified by the BLMK Area Prescribing Committee , May 2025
Clinicians wishing to request Ritlecitinib for treating severe alopecia areata in people
12 years and over, should submit an application via Blueteq.
Guideline Categories: Dermatology
Guideline Areas: Bedfordshire, Luton, Milton Keynes
Guideline Tags: alopecia, Ritlecitinib, severe alopecia areata
Please use the search box to search the whole site if you can't find what you're looking for:
